Emapalumab in pediatric relapsed/refractory hemophagocytic lymphohistiocytosis: clinical responses, attenuated efficacy upon retreatment, and role in bridging to HSCT

Research Square 2026 Preprint Open access

Read full text

Authors: Miner Gu, Susan J. Wu, Jingying Zhang, Fenying Zhao, Juan Liang, Yongmin Tang, Xiaojun Xu

DOI: 10.21203/rs.3.rs-8540730/v1

Cited by: 0

References: 27

Fields of Study & Subjects

Autoimmune and Inflammatory Disorders Research Kawasaki Disease and Coronary Complications Immunodeficiency and Autoimmune Disorders

References 27